Current position of vinorelbine in cancer chemotherapy
- 1 February 1995
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 6 (2) , 105-107
- https://doi.org/10.1093/oxfordjournals.annonc.a059101
Abstract
Jens Benn Sørensen; Current position of vinorelbine in cancer chemotherapy, Annals of Oncology, Volume 6, Issue 2, 1 February 1995, Pages 105–107, https://doi.Keywords
This publication has 10 references indexed in Scilit:
- A phase II trial of vinorelbine and thiotepa in metastatic breast cancerAnnals of Oncology, 1995
- Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's diseaseAnnals of Oncology, 1994
- Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.Journal of Clinical Oncology, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- Treatment of non-small cell lung cancer: new cytostatic agentsLung Cancer, 1993
- Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.Journal of Clinical Oncology, 1993
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInternational Journal of Cancer, 1990